Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Milroy disease and the VEGFR-3 mutation phenotype

Identifieur interne : 001C97 ( Ncbi/Curation ); précédent : 001C96; suivant : 001C98

Milroy disease and the VEGFR-3 mutation phenotype

Auteurs : G. Brice ; A. Child ; A. Evans ; R. Bell ; S. Mansour ; K. Burnand ; M. Sarfarazi ; S. Jeffery ; Peter Mortimer (dermatologue)‎ [Royaume-Uni]

Source :

RBID : PMC:1735984

Descripteurs français

English descriptors

Abstract

Primary congenital lymphoedema (Milroy disease) is a rare autosomal dominant condition for which a major causative gene defect has recently been determined. Mutations in the vascular endothelial growth factor receptor 3 (VEGFR-3) gene have now been described in 13 families world-wide. This is a review of the condition based on the clinical findings in 71 subjects from 10 families. All 71 individuals have a mutation in VEGFR-3. Ninety per cent of the 71 individuals carrying a VEGFR-3 mutation showed signs of oedema, which was confined in all cases to the lower limbs. In all but two cases onset of swelling was from birth. Other symptoms and signs included cellulitis (20%), large calibre leg veins (23%), papillomatosis (10%), and upslanting toenails (10%). In males, hydrocoele was the next most common finding after oedema (37%). Thorough clinical examination of these patients indicates that there are few clinical signs in addition to lower limb oedema. Rigorous phenotyping of patients produces a high yield of VEGFR-3 mutations.


Url:
DOI: 10.1136/jmg.2004.024802
PubMed: 15689446
PubMed Central: 1735984

Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:1735984

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Milroy disease and the
<italic>VEGFR-3</italic>
mutation phenotype</title>
<author>
<name sortKey="Brice, G" sort="Brice, G" uniqKey="Brice G" first="G" last="Brice">G. Brice</name>
</author>
<author>
<name sortKey="Child, A" sort="Child, A" uniqKey="Child A" first="A" last="Child">A. Child</name>
</author>
<author>
<name sortKey="Evans, A" sort="Evans, A" uniqKey="Evans A" first="A" last="Evans">A. Evans</name>
</author>
<author>
<name sortKey="Bell, R" sort="Bell, R" uniqKey="Bell R" first="R" last="Bell">R. Bell</name>
</author>
<author>
<name sortKey="Mansour, S" sort="Mansour, S" uniqKey="Mansour S" first="S" last="Mansour">S. Mansour</name>
</author>
<author>
<name sortKey="Burnand, K" sort="Burnand, K" uniqKey="Burnand K" first="K" last="Burnand">K. Burnand</name>
</author>
<author>
<name sortKey="Sarfarazi, M" sort="Sarfarazi, M" uniqKey="Sarfarazi M" first="M" last="Sarfarazi">M. Sarfarazi</name>
</author>
<author>
<name sortKey="Jeffery, S" sort="Jeffery, S" uniqKey="Jeffery S" first="S" last="Jeffery">S. Jeffery</name>
</author>
<author>
<name sortKey="Mortimer, P" sort="Mortimer, P" uniqKey="Mortimer P" first="P" last="Mortimer">Peter Mortimer (dermatologue)‎</name>
<affiliation>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<orgName type="university">Université de Londres</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">15689446</idno>
<idno type="pmc">1735984</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1735984</idno>
<idno type="RBID">PMC:1735984</idno>
<idno type="doi">10.1136/jmg.2004.024802</idno>
<date when="2005">2005</date>
<idno type="wicri:Area/Pmc/Corpus">004C56</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">004C56</idno>
<idno type="wicri:Area/Pmc/Curation">004C55</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">004C55</idno>
<idno type="wicri:Area/Pmc/Checkpoint">003D54</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">003D54</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="wicri:Area/PubMed/Corpus">003D87</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003D87</idno>
<idno type="wicri:Area/PubMed/Curation">003D87</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003D87</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003D87</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003D87</idno>
<idno type="wicri:Area/Ncbi/Merge">001C97</idno>
<idno type="wicri:Area/Ncbi/Curation">001C97</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Milroy disease and the
<italic>VEGFR-3</italic>
mutation phenotype</title>
<author>
<name sortKey="Brice, G" sort="Brice, G" uniqKey="Brice G" first="G" last="Brice">G. Brice</name>
</author>
<author>
<name sortKey="Child, A" sort="Child, A" uniqKey="Child A" first="A" last="Child">A. Child</name>
</author>
<author>
<name sortKey="Evans, A" sort="Evans, A" uniqKey="Evans A" first="A" last="Evans">A. Evans</name>
</author>
<author>
<name sortKey="Bell, R" sort="Bell, R" uniqKey="Bell R" first="R" last="Bell">R. Bell</name>
</author>
<author>
<name sortKey="Mansour, S" sort="Mansour, S" uniqKey="Mansour S" first="S" last="Mansour">S. Mansour</name>
</author>
<author>
<name sortKey="Burnand, K" sort="Burnand, K" uniqKey="Burnand K" first="K" last="Burnand">K. Burnand</name>
</author>
<author>
<name sortKey="Sarfarazi, M" sort="Sarfarazi, M" uniqKey="Sarfarazi M" first="M" last="Sarfarazi">M. Sarfarazi</name>
</author>
<author>
<name sortKey="Jeffery, S" sort="Jeffery, S" uniqKey="Jeffery S" first="S" last="Jeffery">S. Jeffery</name>
</author>
<author>
<name sortKey="Mortimer, P" sort="Mortimer, P" uniqKey="Mortimer P" first="P" last="Mortimer">Peter Mortimer (dermatologue)‎</name>
<affiliation>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<orgName type="university">Université de Londres</orgName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of Medical Genetics</title>
<idno type="ISSN">0022-2593</idno>
<idno type="eISSN">1468-6244</idno>
<imprint>
<date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Age of Onset</term>
<term>Female</term>
<term>Heterozygote Detection</term>
<term>Humans</term>
<term>Lymphedema (diagnosis)</term>
<term>Lymphedema (epidemiology)</term>
<term>Lymphedema (genetics)</term>
<term>Male</term>
<term>Mutation</term>
<term>Nails, Malformed</term>
<term>Papilloma (pathology)</term>
<term>Phenotype</term>
<term>Saphenous Vein (pathology)</term>
<term>Urogenital Abnormalities (diagnosis)</term>
<term>Varicose Veins (diagnosis)</term>
<term>Vascular Endothelial Growth Factor Receptor-3 (genetics)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte</term>
<term>Détection d'hétérozygote</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphoedème (diagnostic)</term>
<term>Lymphoedème (génétique)</term>
<term>Lymphoedème (épidémiologie)</term>
<term>Malformations urogénitales (diagnostic)</term>
<term>Mutation</term>
<term>Mâle</term>
<term>Ongles malformés</term>
<term>Papillome (anatomopathologie)</term>
<term>Phénotype</term>
<term>Récepteur-3 au facteur croissance endothéliale vasculaire (génétique)</term>
<term>Varices (diagnostic)</term>
<term>Veine saphène (anatomopathologie)</term>
<term>Âge de début</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Vascular Endothelial Growth Factor Receptor-3</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Papillome</term>
<term>Veine saphène</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Lymphedema</term>
<term>Urogenital Abnormalities</term>
<term>Varicose Veins</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Lymphoedème</term>
<term>Malformations urogénitales</term>
<term>Varices</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Lymphoedème</term>
<term>Récepteur-3 au facteur croissance endothéliale vasculaire</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Papilloma</term>
<term>Saphenous Vein</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Age of Onset</term>
<term>Female</term>
<term>Heterozygote Detection</term>
<term>Humans</term>
<term>Male</term>
<term>Mutation</term>
<term>Nails, Malformed</term>
<term>Phenotype</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Détection d'hétérozygote</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mutation</term>
<term>Mâle</term>
<term>Ongles malformés</term>
<term>Phénotype</term>
<term>Âge de début</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p> Primary congenital lymphoedema (Milroy disease) is a rare autosomal dominant condition for which a major causative gene defect has recently been determined. Mutations in the vascular endothelial growth factor receptor 3 (
<italic>VEGFR-3</italic>
) gene have now been described in 13 families world-wide. This is a review of the condition based on the clinical findings in 71 subjects from 10 families. All 71 individuals have a mutation in
<italic>VEGFR-3</italic>
. Ninety per cent of the 71 individuals carrying a
<italic>VEGFR-3</italic>
mutation showed signs of oedema, which was confined in all cases to the lower limbs. In all but two cases onset of swelling was from birth. Other symptoms and signs included cellulitis (20%), large calibre leg veins (23%), papillomatosis (10%), and upslanting toenails (10%). In males, hydrocoele was the next most common finding after oedema (37%). Thorough clinical examination of these patients indicates that there are few clinical signs in addition to lower limb oedema. Rigorous phenotyping of patients produces a high yield of
<italic>VEGFR-3</italic>
mutations. </p>
</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C97 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 001C97 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     PMC:1735984
   |texte=   Milroy disease and the VEGFR-3 mutation phenotype
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:15689446" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024